Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02034318 · ClinicalTrials.gov registry record
Fatigue and Cardiac Sympathetic Denervation in Parkinson Disease
A clinical trial, sponsored by University of Miami.
- Completed
- Registry status
- 25
- Enrollment target
NCT02034318: Completed study, sponsored by University of Miami.
NCT02034318 is a clinical trial that has completed, run by University of Miami. The registered enrollment target is 25 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02034318 has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
Study Summary
The purpose of this research study is to learn about a possible association between cardiac denervation (the breaking down of nerves in the heart) and the development of fatigue in Parkinson's disease (PD).
Primary Outcome
The purpose of this research study is to learn about a possible association between cardiac denervation (the breaking down of nerves in the heart) and the development of fatigue in Parkinson's disease (PD).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2009-03 |
| Est. Completion | 2015-01 |
What the finished NCT02034318 record still lists
NCT02034318 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 25 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02034318 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02034318 about?
NCT02034318 is a clinical study titled "Fatigue and Cardiac Sympathetic Denervation in Parkinson Disease". The purpose of this research study is to learn about a possible association between cardiac denervation (the breaking down of nerves in the heart) and the development of fatigue in Parkinson's disease (PD).
What is the current status of trial NCT02034318?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2009-03. Estimated completion is 2015-01.
Who is sponsoring clinical trial NCT02034318?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia